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Abstract 
The aim of the present study was to prepare gellan gum microspheres of 
Sildenafil citrate, for intranasal delivery to avoid the first pass metabolism. 
The microspheres were prepared using spray drying method. The 
microspheres were evaluated for characteristics like particle size, 
incorporation efficiency, swelling ability, zeta potential, in-vitro 
mucoadhesion, ex-vivo mucoadhesion, thermal analysis, XRD study and in-
vitro drug release. Treatment of in-vitro data to different kinetic equations 
indicated diffusion controlled drug delivery from gellan gum microspheres. 
The results of DSC and XRD studies revealed the molecular amorphous 
dispersion of Sildenafil citrate into the gellan gum microspheres. 
Microspheres so prepared were discrete, bulky, free flowing and showed an 
average encapsulation efficiency ranging from 95-98%. The formulation 
exhibited a good mucoadhesive strength which was determined in  in vitro 
conditions through falling film technique and was compared with ex vivo 
studies. The microspheres so prepared also exhibited a good swelling index 
which confirmed the strong mucoadhesive property of the formulation. 
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Introduction  
Nasal drug delivery has generated interest as an 
alternative route for administration of drugs and 
biomolecules that are susceptible to enzymatic or 
acidic degradation and first pass metabolism. Possible 
pathways for a drug to permeate across the nasal 
mucosa are passive transportation carriers mediated, 
transcytosis and transport through tight junctions. 
However nasal delivery has limitations which have 
restricted its use to the delivery of drug molecules is, 
the general rapid clearance of the administered 
formulation from the nasal cavity due to the 
mucocilliary  clearance  mechanism.  It has been shown  
 
 
 
that for both liquid and powder formulations that are 
not mucoadhesive, the half life of clearance are in the 
order of 15-20 min. different delivery systems based on 
mucoadhesive polymers have been developed which 
are able to increase the residence time of the 
formulation at the absorption site of the drugs. The use 
of mucoadhesive system as microspere is to provide a 
drug protection from enzymatic degradation and thus 
increase the contact time with the nasal mucosa [1, 2]. 
The aim of this work was the possible application of 
gellan gum for the preparation of mucoadhesive micro 
particle for the nasal administration of drugs. 
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Sildenafil is indicated for the treatment of male erectile 
dysfunction. It has been used successfully in males to 
remediate problems associated with impaired neural 
and/or hemodynamic response to sexual stimulation. 
Sildenafil is a cyclic guanosine-specific 
phosphodiesterase type 5 inhibitor that prevents the 
metabolism of cyclic guanosine which produces arterial 
smooth muscle relaxation within the corpora cavernosa 
of the penis and ultimately enhances penile 
tumescence. Inherent to its pharmacology, sildenafil 
produces mild decreases in systolic and diastolic blood 
pressure and an array of minimal side effects due to the 
inhibition of other types of phosphodiesterase. Its 
absolute bioavailability is about 35- 40% after oral 
administration due to first pass metabolism, and its 
plasma half life is about 3-4 hr. Sildinafil is having a 
sufficient lipohillicity with its log P value reported as 
1.9.All these characteristics make it a suitable 
candidate for  nasal delivery. 
Over the past decades, hydrogel polymers have 
attracted a great deal of attention for use as potential 
carriers in site specific delivery. Hydrogels are the 
hydrophilic, three dimensional network structures 
having the natural propensity to absorb large quantity 
of water or biological tissues. Gellan gum is an 
extracellular polysaccharide produced by the bacterium 
Pseudomonas elodea. The natural form of GG is a 
linear anionic hatero polysaccharide based on a 
terasaccharide rapid unit of glucose, glucuronic acid, 
and rhamnose in molar ratio of 2:1:1. The natural form 
of GG is partially acetylated with acetyl and L glyceryl 
groups located on the glucose residues. The presence of 
acetyl groups interferes in ion-bonding ability. On the 
other hand commercially available GG is deacetylated 
product obtained by treatment with alkali. Previous 
studies demonstrated the efficiency of GG in the food 
and pharmaceutical industry. Its pharmaceutical uses 
are mainly concentrated in ophthalmic drug delivery 
and oral sustained release preparations. Due to the 
characteristic property of cation induced gelation, it has 
been widely used in the formulation of insitu gelling 
ophthalmic preparations as well as an insitu gelling oral 
controlled release formulation. It has also been 
suggested that gellan gum is a promising mucoadhesive 
polymer for use in nasal formulations. The gellan gum 
formulation had a residence time of at least 4-5 hrs in 
the nasal cavity without any harmful effects [3, 4]. 
 
Materials and methods 
Materials 
Gellan Gum was obtained as gift sample from Burzin 
and Leons, CPKelco division of the Monsento 
company, USA,  Sildenafil Citrate was gifted by Pfizer 
Mumbai,  India. All the other reagents used were of 
analytical grade. 
 
Methods 
Preparation of Microspheres 
The formulation of microspheres as presented in table 1 
consisted of 1:1 to 1:5 drug to polymer ratios. Gellan 
gum was first dispersed in water and heated upto 80ºC. 
Sildenafil Citrate was then added in the polymer 
solution. The solution of each batch was spray-dried 
(LU222, Labultima, India) keeping the process 
parameters as follows: inlet temperature of 135ºC, 
pump setting of 5ml/min, Spray pressure 2 Kg/cm2. 
The solution was kept at a temperature about 40ºC 
under magnetic stirring, during the spraying process. 
The total volume of solution used for preparation of 
each batch was 200ml. 
 
Table1. Formula for different batches of Sildenafil 
Citrate loaded gellan gum (GGS) microspheres 
 
Formulation 
Code 
Sildenafil 
:GG 
Siuldenafil 
(% w/w) 
GG 
(%w/w) 
GGS1 1:1 1 1 
GGS2 1:2 1 2 
GGS3 1:3 1 3 
GGS4 1:4 1 4 
GGS5 1:5 1 5 
 
Characterization of Microspheres 
1. Morphological examination 
The morphology of microspheres was examined by 
scanning electron microscopy. A small amount of 
powder was spread on an aluminium stub, which was 
placed after gold sputtering in SEM chamber (JSM 
6390®USA). Photographs were taken at an acceleration 
voltage of 20KV electron beam [5, 6]. 
 
2. Production yield, drug content and incorporation 
efficiency 
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Table 2. Characteristics of prepared Sidenafil citrate loaded microspheres. 
 
Formulation 
Code 
Production 
Yield 
(%) 
Drug 
Content 
 (%) 
Incorporation 
Efficiency 
(%±SD)* 
Mean 
Particle size 
(μm±SD)* 
In vitro 
Mucoadhesion 
(%±SD)* 
Degree of 
swelling 
(α) (±SD)* 
GGS1 52.45 53.16 96.13 ±1.25 9.8 ±1.39 86.77± 0.50 0.85 ±0.34 
GGS2 56.70 59.76 98.95 ±2.77 9.71 ±1.21 88.25 ±0.76 0.87 ±0.46 
GGS3 65.52 62.25 98.03 ±1.05 9.75 ±1.88 89.19 ±0.36 0.89± 0.41 
GGS4 
GGS5 
68.34 
71.40 
62.45 
62.54 
95.67 ±1.59 
97.28 ±1.57 
10.1 ±1.15 
11.67±2.52 
89.70 ±0.90 
90.66 ±0.86 
1.10± 0.50 
1.23 ±0.61 
                 *n=3 
 
The production yields of microspheres of various batches 
were calculated using the weight of finally dried 
microspheres with respect to the initial total quantity of 
the drug and polymer used. Percent production yields 
were calculated as per the formula mentioned below, and 
reported in Table 2 [7].        
                 
                             Practical mass (microspheres)   
Production yield =                                                            X 100 
                                Theoretical mass (polymer + drug) 
 
Actual drug content and incorporation efficiency 
 
Actual drug content was determined using UV 
spectrophotometer at a wavelength of 292(UV-
spectrophotometer-1700, Shimadzu, Kyoto, Japan). 
The percent incorporation efficiency was calculated 
from actual drug content. The weighed weighed 
quantity of microspheres (Mactual) and theoretical 
amount of drug and polymers in microspheres 
calculated from the quantity added in the fabrication 
process (Mtheoritical) was substituted in the following 
equation to get the incorporation efficiency [8]. 
 
                                                  Mactual 
%Incorporation efficiency =                   X  100       (1) 
                                                                        Mtheoritical 
 
3. Particle size Measurement 
A microscopic image analysis technique for 
determination of particle size was applied. The 
morphology and particle sizes were determined in a 
Motic DMW2-223 digital microscope (Motic 
Instruments Inc, Canada) equipped with a 1/3” CCD 
camera imaging accessory and computer controlled 
image analysis software (Motic images 2000, 1.3 
version). The microspheres were dispersed on a 
microscope slide. A microscopical field was scanned 
by video camera. The images of the scanned field are 
analyzed by the software. In all measurements at least 
100 particles were examined. 
 
4. Zeta Potential Study 
The microparticles were dispersed in distilled water. 
This dispersion was filled in zeta cell and placed in the 
Zeta Sizer (Nano ZS, Malvern Instruments, and UK). 
The zeta potential was determined with the help of 
software. 
 
5. In Vitro mucoadhesive strength determination 
A freshly cut 2cm2 piece of sheep nasal mucosa was 
obtained and cleaned by washing with isotonic saline 
solution. One hundred milligram of microparticles was 
placed on mucosal surface which was fixed over poly 
ethylene support. About 100μl of simulated nasal 
electrolytes (SNES :aqueous solution containing 8.77 
mg/ml NaCl, 2.98mg/ml KCl and 0.59 mg/ml 
CaCl2)was placed on microspheres and this plate was 
incubated for 15min in desiccators at 90% relative 
humidity to allow the polymer to interact with the 
membrane.  The support was then fixed at an angle of 
45º relative to the horizontal plane. The nasal mucosa 
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was thourghly washed with phosphate buffer (pH 6.6) 
at the rate of 5ml /min using a peristaltic pump. Sixty 
min after administration of microspheres, the 
concentration of drug in collected perfusate was 
spectrophotometrically determined. The microsphere 
amount corresponding to the drug amount in perfusate 
was determined. The adhered microspheres amount 
was estimated from the difference between the applied 
microparticles amount and the flowed microparticles 
amount. The ratio of adhered microparticles was 
computed percent mucoadhesion using following 
equation [9]. 
 
                             Amount of drug in washout liquid 
% Mucoadhesion =                                                                             x 100           (2) 
                                  Actual amount of drug in applied microparticles 
 
 
6. In vitro swelling studies [10] 
The swelling ability of the microspheres in 
physiological media was determined by swelling them 
to their equilibrium. Accurately weighed amounts of 
microspheres (10mg) were placed as Millipore filter 
NY 11, 0.22 μm using a Franz diffusion cell (16ml) 
filled with phosphate buffer pH 6.6 and kept for 3.5 
min. The following formula was then used for 
calculation of degree of swelling 
 
                                   Ws-Wo 
                     α =                                                    (3) 
                                       Ws 
Where α = degree of swelling, Wo = initial weight of 
microspheres 
Ws = weight of microspheres after swelling 
 
7. Thermal Analysis 
Differential scanning calorimetry (DSC) was 
performed on drug loaded and blank microspheres. 
DSC measurement was done on a mettler Toledo DSC 
822c. The thermograms were obtained at a scanning 
rate of 10ºC/min over a temperature range of 20ml/min. 
 
8. X-Ray Diffraction (XRD) Studies 
The crystallinities of Sildenafil citrate and Sildenafil 
citrate loaded microspheres was determined  using an 
x-ray diffractometer (Brrucker Axs, 08 Advance). 
  
9. In vitro drug release [10]  
In vitro drug release test of the microspheres was 
performed using Franz diffusion cell with 
Dialysis membrane (cut off Mol. Weight.12000). The 
membrane was equilibrated before carefully dispersing 
the sample equivalent to 15 mg of drug onto the donor 
compartment. The donor compartment contained 3ml 
of SNES and receiver compartment was filled with 
phosphate buffer solution pH 6.6 that was within the 
pH range in nasal cavity and maintained at 37ºC± 
0.5ºC. Samples were periodically withdrawn from the 
receptor compartment, replaced with the same amount 
of fresh buffer solution, and assayed by a 
spectrophotometer at 292nm. 
 
 
Figure 1. Scanning electron micrograph of Sildenafil 
Citrate loaded microspheres. 
 
10. Histopathological examination of Nasal Mucosa 
The histopathological evaluation of tissue incubated in 
phosphate buffer (pH 6.6) for 6hrs after collection was 
compared with tissue incubated in diffusion chamber 
with formulation. Tissue was fixed in 10% buffered 
formalin, routinely processed and embedded in 
paraffin. Sections were cut on glass slides and stained 
with hematoxylin and eosin. Sections were examined 
under a light microscope to detect damage to the tissue 
[11]. 
 
Results and discussion 
The spray drying technique described here appears to 
be a suitable method for the preparation of gellan gum 
microspheres loaded with Sildenafil Citrate. It is the 
one step process, easy and rapid; also it combines 
drying of the feed and embedding of drug into a one 
step operation. Aqueous solution of gellan gum is 
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known to undergo gelation upto warming to body 
temperature as well as in presence of cations; hence the 
spray drying solution kept at about 40ºC to avoid 
temperature induced gelation during the spray drying 
process. The spray dried microspheres were obtained as 
off white powder. 
 
Table 3. In vitro release kinetic parameter of Sidenafil 
citrate loaded gellan gum microspheres. 
 
Coefficient of Determination        
(R2)  
Formulation 
Code 
Zero 
order 
First 
order 
Highuchi 
GGS1 0.9445 0.9567 0.9883 
GGS2 0.7785 0.9125 0.9567 
GGS3 0.8234 0.9654 0.9854 
GGS4 0.8678 0.9549 0.9834 
GGS5 0.9345 0.9375 0.9971 
 
Characterization of Microsperes 
1. Morphological Examination 
All gellan gum microspheres were spherical with 
smooth surfaces (Fig.1). These microspheres had no 
hole or rupture on the surface, such morphology would 
result in slow clearance and good deposition pattern in 
nasal cavity [12, 13]. 
 
Figure 2. Zeta potential distribution curve of Sildenafil 
loaded gellan gum microspheres. 
 
2. Production yield, Drug content and Incorporation 
efficiency 
The production yield of spray dried microspheres was 
between 50 to 71%. Increasing the concentration of 
polymer slightly increased the yield. As previously 
observed, these values can be justified by the low 
quantity of feed used for the preparation of each batch 
and by the structure of the spray drier, which lacked a 
trap to capture the smallest and lightest particles [14].  
The determination of drug content shows good 
uniformity. In addition, they were close to their 
percentages of theoretical content which were 7.5% to 
2.5% for drug to polymer ratio 1:1 to 1:5. All 
microspheres had good incorporation efficiency 
between 95% and 98% (Table 2). These results indicate 
very good reproducibility of the spray drying method. 
 
3. Particle size measurement 
Particle size of microspheres is one of the most 
important characteristic as a nasal drug delivery. The 
mean particle size of microsperes ranged from 9, 5 to 
11.5μm (Table 2). It has been suggested that 10μm 
particle size is most suitable for nasal administration 
[15].  
 
Figure 3. DSC spectra of Sildenafil , gellan gum blank 
microspheres (GGB) and Sildenafil loaded 
microspheres (GGS). 
 
4. Zeta potential study 
All the microspheres prepared were negatively 
charged, indicating the presence of gellan gum at the 
surface of all microspheres formed (Fig. 2). Studies 
have shown that polymers with charge density can 
serve as good mucoadhesive agents. It has also been 
reported that anion polymers are more effective 
bioadhesive than polycations or non-ionic polymers. 
 
5. In vitro mucoadhesion 
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Mucoadhesion studies were carried out to ensure the 
adhesion of the formulation to the mucosa for a 
prolonged period of time at the site of absorption. 
Percent mucoadhesion was increased with increase in 
polymer concentration (Table 2). This could be because 
of more availability of hydroxyl function groups to 
interaction with mucin. The functional groups available 
on the surface of the polymer favoring mucoadhesion 
include hydroxyl, carboxyl, and amine. Being 
carbohydrate, gellan gum is rich in these functional 
group contents hence showed higher percentage pf 
mucoadhesion [16].  
 
6. In-vitro swelling studies 
In vitro swelling properties of the spray dried 
microspheres were expressed as degree of swelling 
estimated by use of equation (3). Swelling capacity of 
the microspheres was determined by gellan gum in the 
preparation. The maximum swelling (degree of 
swelling) was observed with microspheres containing 
highest concentration of gellan gum (Table 2). 
 
 
Figure 4. X-ray Diffractogram of Sildenafil, gellan 
gum blank microspheres (GGB) and Sildenafil loaded 
microspheres (GGS).  
 
7. Thermal analysis 
 In an effort to assess the physical state of the drug, the 
gellan gum microspheres, we have analyzed Sildenafil 
Citrate (SC), gellan gum blank microspheres (GGB), 
and drug loaded microspheres (GGS) using DSC. The 
results are displayed in Fig.3. The DSC thermogram 
showed a short endothermic peak at 188ºC due to the 
melting of the drug (Fig.3). In blank microspheres 
thermal transition at 251ºC can be see, which is 
attributed to the melting of the gellan gum polymer 
(Fig.3). In the DSC thermogram of the drug loaded 
peak for drug loaded microspheres was not appeared 
(Fig.3). DSC studies revealed that Sildenafil were 
molecularly dispersed inside of the microspheres. 
 
Table 4. Coefficient and exponent of release according 
to Mt/M∞=Ktn for prepared microspheres. 
 
Formulation 
Code 
Kinetic 
Constant 
(k) 
Release 
exponent 
(n) 
Coefficient of 
Determination 
(R2) 
GGS1 -1.532 O.6754 0.9689 
GGS2 -1.239 0.4299 0.9858 
GGS3 -0.937 0.4375 0.9460 
GGS4 
GGS5 
-1.543 
-1.542 
0.5198 
0.4510 
0.9790 
0.9947 
 
8. XRD studies 
The X-ray diffraction spectra recorded for pure 
Sildenafil Citrate (SC) gellan gum blank microspheres 
(GGB) and drug loaded microspheres (GGS) are 
presented in Fig. 4. These studies are useful to 
investigate the crystallinity of drug in the polymeric 
microspheres. Ondansetron has shown characteristic 
intense peaks between 2θ of 5 and 25 but in case of 
blank microspheres and drug loaded microspheres no 
intense peaks were observed between 2θ of 5 and 25, 
indicating amorphous nature of drug after entrapment 
into the gellan gum microspheres by spray drying. 
 
9. In vitro drug Release Study 
The drug release profiles from various formulations of 
microspheres shown in Fig.5. Microspheres prepared 
with gellan gum, moderately sustained the drug release 
to five hrs without any lag time. The rate and extent of 
Sildenafil release from microspheres significantly 
decreased with an increase in gellan concentration. The 
drug release from the microspheres was at slower rate 
due to ionic gelation (cross linking of gellan with 
cations in SNE). 
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Sildenafil release from the multiparticulate system was 
almost complete, regulated and extended until 6   hours 
in F5 batch so the F5 batch was optimized. In order to 
investigate the release mechanism, the release data 
were fitted to models representation zero prder, first 
order and Highuchis square root of time [17]. The 
examination of coefficient of determination values 
indicated that drug release from the microspheres 
formulation followed the diffusion control mechanism 
(Highuchi model). A more stringent test was used to 
distinguish between the mechanisms of drug release. 
 
Release profile of sildenafil citrate from 
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Figure 5. In vitro drug release of Sildenafil citrate from 
microspheres. 
 
The release data were fitted to the Peppas exponential 
model [18, 19]. Mt/M∞ = Ktn , where Mt/M∞ is the 
fraction of drug release after time t, k is the kinetic 
constant and n is the release exponent which 
characterizes the drug transport mechanism. The values 
for kinetic constant and release exponent are listed. The 
n values as shown in table 3 and Table 4 were in the 
range of 0.4510 to 0.6754 indicating that all the 
prepared formulations followed the fickion diffusion 
controlled mechanism of drug release. 
 
10. Histopathological evaluation of nasal mucosa 
The microphotographs were taken of nasal mucosa 
following incubation with microsphere formulations 
for more than six hrs (Fig 6). Examination of tissue 
showed ciliated respiratory epithelium and normal 
goblet cell appearance. None of the severe signs such 
as appearance of epithelial necrosis, sloughing of 
epithelial cells was detected. 
 
Conclusion 
The result of our present study clearly indicated 
promising potentials of gellan gum microspheres for 
delivering drug intranasally and could be viewed as 
attention to conventional dosage form. Gellan gum 
microspheres size of about 10μm and a negative zeta 
potential could be prepared by a conventional spray 
drying method. 
 
 
Figure 6. Light photomicrograph of the microsphere 
treated nasal mucosa.  
 
The microspheres had a good sphericity, a uniform 
distribution of particle size. After getting contact with 
the nasal mucosa, microsphere formulations are 
believed to form viscous gel by withdrawing water 
from the nasal mucosa and interaction with cations 
present in nasal secretions. The resultant gel formation 
decreases the cilliary clearance rate and as a 
consequence the residence time of the formulation at 
the nasal mucosa is prolonged. The mucoadhesive 
properties of microspheres were attributed to 
spontaneous gel formation on nasal mucosa.  
Gellan gum is a biocompatible polymer, it does not 
cause any deleterious effect or toxic response in the 
nasal mucosal cavity even if used for prolonged periods 
was evaluated by histopathological studies. However 
extensive pharmacokinetics and pharmacodynamics 
studies are required to establish a correlation, if any, 
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before establishing Sildenafil nasal delivery as an 
alternative. 
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